Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Herpes zoster
Rotavirus
2022
Europe
Western Pacific
Clear all
Type of publications
NITAG documentation
(41)
Systematic reviews (SYSVAC)
(15)
Topics
Available to download in languages
Regions
Europe
(39)
Western Pacific
(17)
Africa
(23)
Americas
(41)
Eastern Mediterranean
(3)
South-East Asia
(1)
Countries
Australia
(11)
Belgium
(6)
China
(6)
France
(11)
Germany
(2)
Ireland
(4)
Italy
(1)
Luxembourg
(1)
Netherlands
(1)
Spain
(1)
Ukraine
(1)
United Kingdom
(6)
Diseases
COVID-19
(51)
Herpes zoster
(3)
Rotavirus
(2)
Hepatitis B
(1)
Human papillomavirus (HPV)
(8)
Influenza
(5)
Japanese encephalitis
(1)
Meningococcal disease
(1)
Mpox // Monkeypox
(9)
Pertussis
(1)
Pneumococcal disease
(5)
Rabies
(1)
Vaccine topics
Acceptance
(7)
Coverage
(5)
Economic aspects
(2)
Efficacy/effectiveness
(2)
Ethical issues
(4)
Safety
(1)
Target population
Adolescents
(3)
Adults
(6)
All age groups
(8)
Children
(5)
Healthcare workers
(4)
Newborn
(2)
Older adults
(3)
Parents/caregivers
(3)
Pregnant women
(1)
Risk group
(1)
Travellers
(1)
Publication date
2022
(56)
2024
(2)
2023
(21)
2021
(92)
2020
(36)
2019
(3)
2018
(5)
2017
(9)
2016
(5)
2015
(3)
2014
(1)
2013
(2)
2012
(1)
2010
(4)
2009
(1)
2006
(3)
56 results found
2022
∙
Haute Autorité de Santé
Vaccination recommendation against Shingles - Concept note
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)
2022
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
2022
Vaccination recommendations against COVID-19 for the fall in Spain
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19 in France
2022
∙
ATAGI
COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines
2022
∙
ATAGI
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
2022
∙
Haute Autorité de Santé
Place of the Cominarty bivalent vaccines against Covid-19 Original/Omicron BA.1 and Original/Omicron BA.4-5
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register